XTRA:MRKPharmaceuticals
Merck KGaA (XTRA:MRK): Valuation Check After Lateral Flow Assay Market Growth Forecasts Boost Outlook
The latest rally in Merck KGaA (XTRA:MRK) comes as investors latch onto upbeat forecasts for the global lateral flow assay components market, which is expected to expand steadily through 2030 on stronger diagnostic demand.
See our latest analysis for Merck KGaA.
Short term momentum has turned more positive, with an 11.6 percent 3 month share price return taking Merck KGaA to about 119 dollars. However, the 1 year total shareholder return of minus 15.3 percent shows investors are still...